Atlas Trials

Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer

Clinical trial NCT07330583 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07330583
Sponsor
AHS Cancer Control Alberta
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2026-03-01
Primary completion
2028-10-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.